Novant Health Medical Group, LLC
Novant Health Medical Group, LLC was paid $3.02M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 59% of everything it billed.
SHALLOTTE, NC 28470
Next to other Family Medicine Physician providers in North Carolina
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,913 | $368K | |
| 2019 | 15,199 | $445K | |
| 2020 | 10,042 | $407K | |
| 2021 | 21,689 | $667K | |
| 2022 | 33,120 | $674K | |
| 2023 | 28,212 | $392K | |
| 2024incomplete | 23,622 | $67K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 59% | 26,671 | 23,629 | $1.79M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 11,139 | 9,680 | $577K |
| 99199 | Unlisted special service, procedure or report | 8.8% | 74,005 | 72,668 | $267K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.3% | 7,314 | 6,076 | $131K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 3,447 | 1,614 | $45K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.4% | 2,535 | 1,949 | $43K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.0% | 520 | 501 | $32K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 846 | 744 | $24K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 413 | 381 | $24K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 286 | 227 | $23K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 304 | 289 | $18K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,054 | 992 | $14K |
48 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 145 | $6K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 138 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 539 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 179 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 25 | $3K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 29 | $3K |
| 99201 | <1% | 64 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 301 | $1K |
| 87807 | <1% | 118 | $1K | |
| 81003 | <1% | 647 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 29 | $602.89 |
| 94060 | <1% | 54 | $364.90 | |
| 94726 | <1% | 53 | $247.10 | |
| 99406 | <1% | 29 | $245.83 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 31 | $214.19 |
| 94729 | <1% | 53 | $163.80 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 29 | $158.64 |
| 90734 | <1% | 24 | $147.84 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 19 | $111.98 |
| 90686 | <1% | 15 | $20.45 | |
| 90461 | <1% | 14 | $15.71 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $14.40 |
| 99173 | <1% | 18 | $2.04 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 3,558 | $0.00 |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 0% | 3,298 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 445 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 670 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 254 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 98 | $0.00 |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 148 | $0.00 |
| 4040F | 0% | 88 | $0.00 | |
| 3023F | 0% | 106 | $0.00 | |
| 4004F | 0% | 14 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 13 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 0% | 1,296 | $0.00 |
| G8536 | No documentation of an elder maltreatment screen, reason not given | 0% | 591 | $0.00 |
| 1036F | 0% | 1,382 | $0.00 | |
| G8732 | No documentation of pain assessment, reason not given | 0% | 2,680 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 802 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 267 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 265 | $0.00 |
| 1123F | 0% | 76 | $0.00 | |
| 3017F | 0% | 326 | $0.00 | |
| G8926 | Spirometry test not performed or documented, reason not given | 0% | 176 | $0.00 |
| 1101F | 0% | 74 | $0.00 | |
| 92551 | 0% | 18 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 25 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.